Form D · Other Technology
PhageTech, Inc.
Irvine, CA · CIK 0001659912
Offering snapshot reported May 24, 2017 · SEC filing
- Reported sold
- $500K Offering amount: $4.01M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $15K Reported outside-investor minimum
- First sale
- May 11, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 24, 2017 | Initial | $500,000 | No comparison | 10 | SEC filing |
| Dec 3, 2015 | Initial | $1,650,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-287337
Series A Preferred Stock and Warrants
Source: Form D, filed May 24, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Paul Cate | Director |
| Richard W. Henson | Director |
| Marc D. Kelly | Executive |
| Jeff Manassero | Executive |
| Reuben Richards | Director, Executive |
| Jacob Van Berkel | Director |
| Gregory Weiss | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
5151 California Ave, Ste 100
Irvine, CA, 92617
Irvine, CA, 92617